EKF Diagnostics, a manufacturer of medical devices, has been awarded a contract to supply the State of New Mexico's Women, Infants, and Children (WIC) clinics with its point-of-care haemoglobin testing instrument.
The initial order is for 220 instruments which will be supplied to over 100 WIC clinics throughout the US State and will be used to carry out tests for anemia.
Anemia is one of the most common blood conditions in the US, affecting about 3.5m Americans.
Subscribe to MoneyWeek
Subscribe to MoneyWeek today and get your first six magazine issues absolutely FREE
Sign up to Money Morning
Don't miss the latest investment and personal finances news, market analysis, plus money-saving tips with our free twice-daily newsletter
Don't miss the latest investment and personal finances news, market analysis, plus money-saving tips with our free twice-daily newsletter
An initial indication from the New Mexico WIC clinics suggests that they expect to perform more than 160,000 tests per year using the HemoPoint H2 instrument.
Julian Baines, Chief Executive of EKF, said: "Following on from our recent trading update, which showed strong trading for 2011 ahead of expectations, the news of this contract win reinforces our belief that EKF will deliver continued organic growth in 2012, particularly as we ramp up sales of our HemoPoint H2 instruments in the key market of North America."
The share price rose 5% to 26.25p by 09:36.
NR
-
Why undersea cables are under threat – and how to protect themUndersea cables power the internet and are vital to modern economies. They are now vulnerable
-
Vanguard to bring in £4 minimum monthly fee - is it still a cheap deal?Vanguard is overhauling its charges, with DIY investors set to pay more from January. How will the fees compare to its rivals, and what should customers do?
